Bovine retinal pericytes are resistant to glucose-induced oxidative stress in vitro

Antioxidants and Redox Signaling

Volumn 7, Issue 11-12, 2005, Pages 1486-1493

  Agardh, Carl David ^a   Hultberg, Björn ^a   Nayak, Ramesh C ^b   Farthing Nayak, Pamela ^b   Agardh, Elisabet ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ENZYME; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; THIOL DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LOSS; CONTROLLED STUDY; COW; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA;

ANIMALS; ANTIOXIDANTS; CATTLE; CELLS, CULTURED; GLUCOSE; GLUTATHIONE; MALONDIALDEHYDE; MUSCLE, SMOOTH; OXIDATIVE STRESS; PERICYTES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

ANIMALIA; BOVINAE;

EID: 28844503196     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1486     Document Type: Article

References (50)

1. Agardh CD, Agardh E, Hultberg B, Qian Y, and Östenson CG. The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. Curr Eye Res 17: 251-256, 1998.
2. Agardh CD, Agardh E, Qian Y, and Hultberg B. Glutathione levels are reduced in diabetic rat retina but are not influenced by ischemia followed by recirculation. Metabolism 47: 269-272, 1998.
3. Agardh E, Hultberg B, and Agardh CD. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr Eye Res 21: 543-549, 2000.
4. Ansari NH, Zhang W, Fulep E, and Mansour A. Prevention of pericyte loss by Trolox in diabetic rat retina. J Toxicol Environ Health A24: 467-475, 1998.
5. Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, and Bojancyzk M. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. J Diabetes Complications 6: 116-122, 1992.
6. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
7. Bobbink IW, de Boer HC, Tekelenburg WL, Banga JD, and de Groot PG. Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin. Diabetes 46: 87-93, 1997.
8. Breborowicz A, Breborowicz M, and Oreopoulos DG. Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid. Am J Nephrol 23: 471-476, 2003.
9. Cameron NE, Cotter MA, Archibald V, Dines KC, and Maxfield EK. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneural blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449-459, 1994.
10. Cheng H, Kartenbeck J, Kabsch K, Mao X, Marques M, and Alonso A. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol. J Cell Physiol 192: 234-243, 2002.
11. Crouch R, Kimsey G, Priest DG, Sarda A, and Buse MG. Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia 15: 53-57, 1978.
12. DAMAD Study Group: Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. Diabetes 38: 491-498, 1989.
13. De Oliveira F. Pericytes in diabetic retinopathy. Br J Ophthalmol 50: 134-143, 1966.
14. DeRubertis FR and Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43: 1-8, 1994.
15. Early Treatment of Diabetic Retinopathy Research Group: Effects of aspirin treatment on diabetic retinopathy. EDTRS report number 8. Ophthalmology 98: 757-765, 1991.
16. Ellis EA, Grant MB, Murrey FT, Wachowski MB, Guberski DL, Kubilis PS, and Lutty GA. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24: 111-120, 1998.
17. Gardiner TA, Anderson HR, Degenhardt T, Thorpe SR, Baynes JW, Archer DB, and Stitt AW. Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug. Diabetologia 46: 1269-1275, 2003.
18. Kammes HP, Bartmann A, Engel L, and Wülfroth P. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40: 629-634, 1997.
19. Hammes HP, Wellensiek B, Klöting I, Sickel E, Bretzel RG, and Brownlee M. The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 41: 165-170, 1998.
20. Hultberg B, Andersson A, and Isaksson A. Thiol and redox reactive agents exert different effects on glutathione metabolism in HeLa cell cultures. Clin Chim Acta 283: 21-32, 1999.
21. Hunt JV, Dean RT, and Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J 256: 205-212, 1988.
22. Jiang YZ, Towler HMA, Luthert P, and Lightman S. Pathophysiology of diabetic retinopathy. In: Diabetes Mellitus, edited by LeRoith D, Taylor SI, and Olefsky JM. Philadelphia, PA: Lippincott-Raven, 1996, pp. 719-727.
23. Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, and Tsilibary EC. Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci 36: 2358-2367, 1995.
24. Kern TS and Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50: 1636-1642, 2001.
25. Klein RR. The epidemiology of diabetic retinopathy. In: Textbook of Diabetes: Vol. 2, edited by Pickup J and Williams G. Oxford: Blackwell, 1991, pp. 557-563.
26. Kowluru R, Kern TS, and Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 13: 891-896, 1994.
27. Kowluru RA, Kern TS, Engerman RL, and Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 45: 1233-1237, 1996.
28. Kowluru RA, Kern TS, and Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 22: 587-592, 1997.
29. Kowluru RA, Jirousek MR, Stramm LE, Fand NA, Engerman RL, and Kern TS. Abnormalities of retinal metabolism in diabetes or galactosemia. Relationship between protein kinase C and ATPases. Diabetes 47: 464-469, 1998.
30. Kowluru RA, Engerman RL, and Kern TS. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res 32: 67-74, 2000.
31. Kowluru RA, Tang J, and Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50: 1938-1942, 2001.
32. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
33. Malek AM, Goss GG, Jiang L, Izumo S, and Alper SL. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 29: 2631-2640, 1998.
34. Matés JM and Sánchez-Jimenéz F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4: D339-D345, 1999.
35. Nayak RC, Berman AB, George KL, Eisenbarth GS and King GL. A monoclonal antibody (3G5) defined ganglioside antigen is expressed on the cell surface on microvascular pericytes. J Exp Med 167: 1003-1015, 1988.
36. Omori K, Fujiseki Y, Omori K, Suzukawa J, and Inagaki C. Regulation of the expression of lysyl oxidase mRNA in cultured rabbit retinal pigment epithelium cells. Matrix Biol 21: 337-348, 2002.
37. Sharpe PC, Liu W-H, Yue KKM, McMaster D, Catherwood MA, McGinty AM, and Trimble ER. Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes 47: 801-809, 1998.
38. Soulis-Liparota T, Cooper ME, Dunlop M, and Jerums G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38: 387-394, 1995.
39. Spranger J and Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 109: S438-S450, 2001.
40. Stüzenbaum SR and Kille P. Control genes in quantitative molecular biological techniques: the variability of invariance. Comp Biochem Physiol Biochem Mol Biol 130: 281-289, 2001.
41. Takahashi K and Cohen HJ. Selenium-dependent glutathione peroxidase protein and activity: immunological investigation on cellular and plasma enzymes. Blood 68: 640-645, 1986.
42. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
43. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865, 1998.
44. Uzel N, Sivas A, Uysal M, and Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res 19: 89-90, 1987.
45. Watanabe J, Umeda F, Wakasugi H, and Ibayashi H. Effect of vitamin E on platelet aggregation in diabetes mellitus. Thromb Haemost 51: 313-316, 1984.
46. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, and Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993.
47. Winkler BS, DeSantis N, and Solomon F. Multiple NADPH-producing pathways control glutathione (GSH) content in retina. Exp Eye Res 43: 829-847, 1986.
48. Wolff SP and Dean RT. Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem J 245: 243-250, 1987.
49. Zakowski JJ, Forstrom JW, Condell RA, and Tappel AL. Attachment of selenocysteine in the catalytic site of glutathione peroxidase. Biochem Biophys Res Commun 84: 248-253, 1978.
50. Zhang W, Andersson BS, and Hahn RG. Effect of irrigating fluids and prostate tissue extracts on isolated cardiomyocytes. Urology 46: 821-824, 1995.